These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28738187)

  • 1. Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study.
    Kinnunen KM; Cash DM; Poole T; Frost C; Benzinger TLS; Ahsan RL; Leung KK; Cardoso MJ; Modat M; Malone IB; Morris JC; Bateman RJ; Marcus DS; Goate A; Salloway SP; Correia S; Sperling RA; Chhatwal JP; Mayeux RP; Brickman AM; Martins RN; Farlow MR; Ghetti B; Saykin AJ; Jack CR; Schofield PR; McDade E; Weiner MW; Ringman JM; Thompson PM; Masters CL; Rowe CC; Rossor MN; Ourselin S; Fox NC;
    Alzheimers Dement; 2018 Jan; 14(1):43-53. PubMed ID: 28738187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.
    Fujishima M; Kawaguchi A; Maikusa N; Kuwano R; Iwatsubo T; Matsuda H; ;
    J Alzheimers Dis; 2017; 56(1):75-88. PubMed ID: 27911297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of Accelerated and Non-accelerated MRI Scans for Brain Volume and Boundary Shift Integral Measures of Volume Change: Evidence from the ADNI Dataset.
    Manning EN; Leung KK; Nicholas JM; Malone IB; Cardoso MJ; Schott JM; Fox NC; Barnes J;
    Neuroinformatics; 2017 Apr; 15(2):215-226. PubMed ID: 28316055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease.
    Vogel JW; Vachon-Presseau E; Pichet Binette A; Tam A; Orban P; La Joie R; Savard M; Picard C; Poirier J; Bellec P; Breitner JCS; Villeneuve S;
    Brain; 2018 Jun; 141(6):1871-1883. PubMed ID: 29688388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
    Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL
    Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study.
    Ridha BH; Barnes J; Bartlett JW; Godbolt A; Pepple T; Rossor MN; Fox NC
    Lancet Neurol; 2006 Oct; 5(10):828-34. PubMed ID: 16987729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.
    Leung KK; Bartlett JW; Barnes J; Manning EN; Ourselin S; Fox NC;
    Neurology; 2013 Feb; 80(7):648-54. PubMed ID: 23303849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.
    Jack CR; Lowe VJ; Weigand SD; Wiste HJ; Senjem ML; Knopman DS; Shiung MM; Gunter JL; Boeve BF; Kemp BJ; Weiner M; Petersen RC;
    Brain; 2009 May; 132(Pt 5):1355-65. PubMed ID: 19339253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates of cerebral atrophy differ in different degenerative pathologies.
    Whitwell JL; Jack CR; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Ferman TJ; Dickson DW; Josephs KA
    Brain; 2007 Apr; 130(Pt 4):1148-58. PubMed ID: 17347250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological correlates of whole brain atrophy in Alzheimer's disease.
    Schott JM; Crutch SJ; Frost C; Warrington EK; Rossor MN; Fox NC
    Neuropsychologia; 2008; 46(6):1732-7. PubMed ID: 18395233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
    Josephs KA; Martin PR; Weigand SD; Tosakulwong N; Buciuc M; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Dickson DW; Jack CR; Whitwell JL
    Brain; 2020 Dec; 143(11):3463-3476. PubMed ID: 33150361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates.
    Chen K; Reiman EM; Alexander GE; Caselli RJ; Gerkin R; Bandy D; Domb A; Osborne D; Fox N; Crum WR; Saunders AM; Hardy J
    Am J Psychiatry; 2007 Jun; 164(6):916-21. PubMed ID: 17541051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression.
    Ridha BH; Anderson VM; Barnes J; Boyes RG; Price SL; Rossor MN; Whitwell JL; Jenkins L; Black RS; Grundman M; Fox NC
    J Neurol; 2008 Apr; 255(4):567-74. PubMed ID: 18274807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease.
    Twohig D; Rodriguez-Vieitez E; Sando SB; Berge G; Lauridsen C; Møller I; Grøntvedt GR; Bråthen G; Patra K; Bu G; Benzinger TLS; Karch CM; Fagan A; Morris JC; Bateman RJ; Nordberg A; White LR; Nielsen HM;
    Acta Neuropathol Commun; 2018 Nov; 6(1):130. PubMed ID: 30477568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.
    Davatzikos C; Xu F; An Y; Fan Y; Resnick SM
    Brain; 2009 Aug; 132(Pt 8):2026-35. PubMed ID: 19416949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consistent multi-time-point brain atrophy estimation from the boundary shift integral.
    Leung KK; Ridgway GR; Ourselin S; Fox NC;
    Neuroimage; 2012 Feb; 59(4):3995-4005. PubMed ID: 22056457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).
    Niemantsverdriet E; Ribbens A; Bastin C; Benoit F; Bergmans B; Bier JC; Bladt R; Claes L; De Deyn PP; Deryck O; Hanseeuw B; Ivanoiu A; Lemper JC; Mormont E; Picard G; Salmon E; Segers K; Sieben A; Smeets D; Struyfs H; Thiery E; Tournoy J; Triau E; Vanbinst AM; Versijpt J; Bjerke M; Engelborghs S
    J Alzheimers Dis; 2018; 63(4):1509-1522. PubMed ID: 29782314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-amyloid burden is not associated with rates of brain atrophy.
    Josephs KA; Whitwell JL; Ahmed Z; Shiung MM; Weigand SD; Knopman DS; Boeve BF; Parisi JE; Petersen RC; Dickson DW; Jack CR
    Ann Neurol; 2008 Feb; 63(2):204-12. PubMed ID: 17894374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cerebellum shrinks faster than normal ageing in Alzheimer's disease but not in mild cognitive impairment.
    Tabatabaei-Jafari H; Walsh E; Shaw ME; Cherbuin N;
    Hum Brain Mapp; 2017 Jun; 38(6):3141-3150. PubMed ID: 28321950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.